Advancing precision medicine for acute respiratory distress syndrome. (2022)
Attributed to:
Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunctio
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(21)00157-0
PubMed Identifier: 34310901
Publication URI: http://europepmc.org/abstract/MED/34310901
Type: Journal Article/Review
Volume: 10
Parent Publication: The Lancet. Respiratory medicine
Issue: 1
ISSN: 2213-2600